ENST00000588705.1:n.*58T>C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000588705.1(ENSG00000267228):​n.*58T>C variant causes a splice region, non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00487 in 1,055,584 control chromosomes in the GnomAD database, including 213 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0052 ( 27 hom., cov: 32)
Exomes 𝑓: 0.0048 ( 186 hom. )

Consequence

ENSG00000267228
ENST00000588705.1 splice_region, non_coding_transcript_exon

Scores

2
Splicing: ADA: 0.00003319
2

Clinical Significance

Likely benign criteria provided, single submitter P:1B:3

Conservation

PhyloP100: 0.129

Publications

2 publications found
Variant links:
Genes affected
IER3IP1 (HGNC:18550): (immediate early response 3 interacting protein 1) This gene encodes a small protein that is localized to the endoplasmic reticulum (ER) and may play a role in the ER stress response by mediating cell differentiation and apoptosis. Transcription of this gene is regulated by tumor necrosis factor alpha and specificity protein 1 (Sp1). Mutations in this gene may play a role in microcephaly, epilepsy, and diabetes syndrome (MEDS), and a pseudogene of this gene is located on the long arm of chromosome 12. [provided by RefSeq, Dec 2011]
IER3IP1 Gene-Disease associations (from GenCC):
  • microcephaly, epilepsy, and diabetes syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • primary microcephaly-epilepsy-permanent neonatal diabetes syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 18-47156119-A-G is Benign according to our data. Variant chr18-47156119-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 433137.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.101 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IER3IP1NM_016097.5 linkc.*58T>C 3_prime_UTR_variant Exon 3 of 3 ENST00000256433.6 NP_057181.1 Q9Y5U9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000267228ENST00000588705.1 linkn.*58T>C splice_region_variant, non_coding_transcript_exon_variant Exon 3 of 6 2 ENSP00000465194.1
IER3IP1ENST00000256433.6 linkc.*58T>C 3_prime_UTR_variant Exon 3 of 3 1 NM_016097.5 ENSP00000256433.3 Q9Y5U9
ENSG00000267228ENST00000588705.1 linkn.*58T>C 3_prime_UTR_variant Exon 3 of 6 2 ENSP00000465194.1

Frequencies

GnomAD3 genomes
AF:
0.00524
AC:
798
AN:
152182
Hom.:
27
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.108
Gnomad SAS
AF:
0.00518
Gnomad FIN
AF:
0.00547
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000588
Gnomad OTH
AF:
0.00717
GnomAD4 exome
AF:
0.00481
AC:
4347
AN:
903284
Hom.:
186
Cov.:
12
AF XY:
0.00455
AC XY:
2148
AN XY:
472322
show subpopulations
African (AFR)
AF:
0.00107
AC:
24
AN:
22440
American (AMR)
AF:
0.000211
AC:
9
AN:
42572
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
78
AN:
22562
East Asian (EAS)
AF:
0.0850
AC:
3148
AN:
37056
South Asian (SAS)
AF:
0.00172
AC:
125
AN:
72486
European-Finnish (FIN)
AF:
0.00473
AC:
251
AN:
53030
Middle Eastern (MID)
AF:
0.000518
AC:
2
AN:
3860
European-Non Finnish (NFE)
AF:
0.000596
AC:
362
AN:
607234
Other (OTH)
AF:
0.00828
AC:
348
AN:
42044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
196
393
589
786
982
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00524
AC:
798
AN:
152300
Hom.:
27
Cov.:
32
AF XY:
0.00593
AC XY:
442
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41574
American (AMR)
AF:
0.00216
AC:
33
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3470
East Asian (EAS)
AF:
0.109
AC:
564
AN:
5192
South Asian (SAS)
AF:
0.00497
AC:
24
AN:
4826
European-Finnish (FIN)
AF:
0.00547
AC:
58
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000588
AC:
40
AN:
68026
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
40
81
121
162
202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00191
Hom.:
1
Bravo
AF:
0.00603
Asia WGS
AF:
0.0460
AC:
160
AN:
3474

ClinVar

Significance: Likely benign
Submissions summary: Pathogenic:1Benign:3
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Self-limited epilepsy with centrotemporal spikes Pathogenic:1
Jan 01, 2017
Bioinformatics Core, Luxembourg Center for Systems Biomedicine
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:case-control

CAADphred>15 -

not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

IER3IP1-related disorder Benign:1
May 24, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Epilepsy Benign:1
Jan 06, 2020
Reproductive Health Research and Development, BGI Genomics
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:curation

NM_016097.4:c.*58T>C in the IER3IP1 gene has an allele frequency of 0.008 in the gnomAD database, including 12 homozygous occurrences. The allele frequency is 0.1321 in the Asian subpopulation (total allele is less than 2000). Benign computational verdict because benign prediction from DANN. Taken together, we interprete this variant as Benign/Likely benign variant. ACMG/AMP criteria applied: BS2; BP4. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
3.4
DANN
Benign
0.64
PhyloP100
0.13
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000033
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150586939; hg19: chr18-44682490; COSMIC: COSV107209187; COSMIC: COSV107209187; API